The effects of centrally acting peptides on the chronic actions of buprenorphine in the rat.
D000818:Animals; D002047:Buprenorphine / Q000008:administration & dosage / Q000494:pharmacology*; D004151:Dipeptides / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D009075:MSH Release-Inhibiting Hormone / Q000494:pharmacology*; D008297:Male; D009019:Morphinans / Q000494:pharmacology*; D009479:Neuropeptides; D010456:Peptides, Cyclic; D051381:Rats; D011919:Rats, Inbred Strains
D004151:Dipeptides; D009019:Morphinans; D009479:Neuropeptides; D010456:Peptides, Cyclic; D002047:Buprenorphine; C021166:cyclo(leucylglycine); D009075:MSH Release-Inhibiting Hormone